ISPC vs JLL · rev $9.3M vs P/E 23, rev $23.43B
iSpecimen Inc (ISPC) versus Jones Lang LaSalle Incorporated (JLL) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported JLL revenue for 2024-12-31 was $23.43B. Net income was $546.8M. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
ISPC currently screens at market cap $4.4M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Not investment advice. Open the ISPC and JLL stock pages for the full models.
Not investment advice.